Medical Marijuana I
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. It engages in creating international CBD pipeline; produces legal cannabis products; develops cannabis drug and medication; supports services for cannabis industry; and develops market for medical cannabis. Medical Marijuana, Inc. was incorporated in 2005 and is based in Vista, Califo… Read more
Medical Marijuana I - Asset Resilience Ratio
Medical Marijuana I (MJNA) has an Asset Resilience Ratio of 0.03% as of December 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2021)
This chart shows how Medical Marijuana I's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Medical Marijuana I's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $27.49K | 0.03% |
| Total Liquid Assets | $27.49K | 0.03% |
Asset Resilience Insights
- Limited Liquidity: Medical Marijuana I maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Medical Marijuana I Industry Peers by Asset Resilience Ratio
Compare Medical Marijuana I's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Medical Marijuana I (2012–2021)
The table below shows the annual Asset Resilience Ratio data for Medical Marijuana I.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | 0.03% | $27.49K | $80.72 Million | +0.00pp |
| 2020-12-31 | 0.03% | $27.49K | $84.32 Million | +0.02pp |
| 2019-12-31 | 0.02% | $27.49K | $179.61 Million | -0.06pp |
| 2018-12-31 | 0.07% | $68.95K | $92.96 Million | +0.07pp |
| 2017-12-31 | 0.01% | $17.74K | $274.84 Million | +0.00pp |
| 2016-12-31 | 0.01% | $21.85K | $393.55 Million | -0.92pp |
| 2015-12-31 | 0.93% | $2.00 Million | $216.18 Million | +0.86pp |
| 2014-12-31 | 0.06% | $107.36K | $166.09 Million | -65.17pp |
| 2013-12-31 | 65.24% | $30.42 Million | $46.63 Million | +55.68pp |
| 2012-12-31 | 9.55% | $1.57 Million | $16.38 Million | -- |